Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects with Multiple Sclerosis ClinicalTrials.gov, 19 Dec 2009 Accessed on 19 Dec 2011 from http://clinicaltrials.gov/ct2/show/NCT00411723. CommentRecommendBookmarkWatch